@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sct: <http://snomed.info/id/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<https://www.medizin.uni-greifswald.de/fhir/guideline/cll/PlanDefinition/CLLTherapieindikationBinetC> a fhir:PlanDefinition ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "CLLTherapieindikationBinetC"] ; # 
  fhir:meta [
     fhir:profile ( [
       fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation-plan"^^xsd:anyURI ;
       fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/recommendation-plan>
     ] )
  ] ; # 
  fhir:text [
     fhir:status [ fhir:v "extensions" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: PlanDefinition CLLTherapieindikationBinetC</b></p><a name=\"CLLTherapieindikationBinetC\"> </a><a name=\"hcCLLTherapieindikationBinetC\"> </a><a name=\"CLLTherapieindikationBinetC-en-US\"> </a><p><b>partOf</b>: <a href=\"PlanDefinition-RecCollectionTherapieplanungBinetCLL.html\">Recommendation Collection CLL: Therapieindikation nach Binet Stadium (4.1)</a></p><blockquote><p><b>Action Combination Method</b></p><ul><li>method: <span title=\"Codes:{https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method all}\">All</span></li></ul></blockquote><p><b>knowledgeCapability</b>: computable</p><p><b>knowledgeRepresentationLevel</b>: structured</p><p><b>url</b>: <a href=\"PlanDefinition-CLLTherapieindikationBinetC.html\">PlanDefinition CLL Therapieindikation Binet C</a></p><p><b>version</b>: Langversion 2.01</p><p><b>name</b>: CLLTherapieindikationBinetC</p><p><b>title</b>: CLL Therapieindikation Binet C</p><p><b>type</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/plan-definition-type eca-rule}\">ECA Rule</span></p><p><b>status</b>: Active</p><p><b>experimental</b>: false</p><p><b>subject</b>: <a href=\"EvidenceVariable-PopulationCLLBinetC.html\">Population: CLL und Binet Stadium C</a></p><p><b>date</b>: 2023-05</p><p><b>publisher</b>: https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll</p><p><b>description</b>: </p><div><p>Die Indikation zur Therapie besteht bei Übergang in Stadium Binet C</p>\n</div><h3>Actions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Definition[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 386053000}\">Evaluation procedure (procedure)</span></td><td><a href=\"ActivityDefinition-TherapieIndikationCLL.html\">TherapieIndikationCLL</a></td></tr></table></div>"
  ] ; # 
  fhir:extension ( [
     fhir:url [ fhir:v "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-partOf"^^xsd:anyURI ] ;
     fhir:value [
       fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommendation/therapeutic-anticoagulation"^^xsd:anyURI ;
       fhir:link <https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/guideline/covid19-inpatient-therapy/recommendation/therapeutic-anticoagulation>
     ]
  ] [
     fhir:extension ( [
       fhir:url [ fhir:v "method"^^xsd:anyURI ] ;
       fhir:value [
         a fhir:CodeableConcept ;
         fhir:coding ( [
           fhir:system [ fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/CodeSystem/cs-action-combination-method"^^xsd:anyURI ] ;
           fhir:code [ fhir:v "all" ]
         ] )
       ]
     ] ) ;
     fhir:url [ fhir:v "https://www.netzwerk-universitaetsmedizin.de/fhir/cpg-on-ebm-on-fhir/StructureDefinition/ext-action-combination-method"^^xsd:anyURI ]
  ] [
     fhir:url [ fhir:v "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability"^^xsd:anyURI ] ;
     fhir:value [ fhir:v "computable" ]
  ] [
     fhir:url [ fhir:v "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel"^^xsd:anyURI ] ;
     fhir:value [ fhir:v "structured" ]
  ] ) ; # 
  fhir:url [ fhir:v "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/PlanDefinition/CLLTherapieindikationBinetC"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "Langversion 2.01"] ; # 
  fhir:name [ fhir:v "CLLTherapieindikationBinetC"] ; # 
  fhir:title [ fhir:v "CLL Therapieindikation Binet C"] ; # 
  fhir:type [
     fhir:coding ( [
       fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/plan-definition-type"^^xsd:anyURI ] ;
       fhir:code [ fhir:v "eca-rule" ]
     ] )
  ] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:experimental [ fhir:v "false"^^xsd:boolean] ; # 
  fhir:subject [
     fhir:v "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/EvidenceVariable/PopulationCLLBinetC"^^xsd:anyURI ;
     fhir:link <https://www.medizin.uni-greifswald.de/fhir/guideline/cll/EvidenceVariable/PopulationCLLBinetC>
  ] ; # 
  fhir:date [ fhir:v "2023-05"^^xsd:gYearMonth] ; # 
  fhir:publisher [ fhir:v "https://www.leitlinienprogramm-onkologie.de/leitlinien/s3-leitlinie-zur-diagnostik-therapie-und-nachsorge-fuer-patienten-mit-einer-chronischen-lymphatischen-leukaemie-cll"] ; # 
  fhir:description [ fhir:v "Die Indikation zur Therapie besteht bei Übergang in Stadium Binet C"] ; # 
  fhir:action ( [
     fhir:code [
       fhir:coding ( [
         a sct:386053000 ;
         fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
         fhir:code [ fhir:v "386053000" ] ;
         fhir:display [ fhir:v "Evaluation procedure (procedure)" ]
       ] )
     ] ;
     fhir:definition [
       fhir:v "https://www.medizin.uni-greifswald.de/fhir/guideline/cll/ActivityDefinition/TherapieIndikationCLL"^^xsd:anyURI ;
       fhir:link <https://www.medizin.uni-greifswald.de/fhir/guideline/cll/ActivityDefinition/TherapieIndikationCLL>
     ]
  ] ) . # 

# -------------------------------------------------------------------------------------

